PRESS RELEASE
McDermott and EY Gather Leading Health and Life Sciences Leaders at Annual J.P. Morgan Healthcare Conference
January 4, 2021
Read time: 6 min
Leading health law firm McDermott Will & Emery, together with EY, is hosting its 2021 J.P. Morgan Healthcare Conference in four virtual sessions on January 7 and January 11-13, 2021. The sessions will explore critical business and legal issues encountered by those investing in and shaping the healthcare and life sciences markets as the industry shifts in a post-COVID landscape.
“This symposium is a collection of the brightest minds advancing innovations and outcomes in the health, life sciences, private equity and hospital and health systems sphere,” said Ira Coleman, Chairman of McDermott Will & Emery. “Although we cannot be together in person this year, this event will continue to provide critical opportunities to facilitate unique industry partnerships to advance effective and long-term strategies.”
The four sessions include:
Digital Health: Thursday, January 7, 2021, 12 – 2 PM EST
Session will discuss the evolving doctor-patient relationship and the digitized data and technology convergence with healthcare delivery and payment, including insight into 2021’s regulatory considerations affecting healthcare innovation and its solutions.
Life Sciences Investment Forum (three topics)
Biopharma: Monday, January 11, 2021, 10 – 11 AM EST
Topics include how current high valuations and liquidity play into deal considerations in a COVID and post-COVID world; the continued importance of therapy area focus and its impact on dealmaking; how strategic buyers and sellers can work with private equity in the current environment; how M&A and partnering will be used to add capabilities required to deliver care in the home as virtual care becomes the norm.
MedTech: Monday, January 11, 2021, 11 AM – 12 PM EST
M&A leaders from medtech organizations and private equity firms focused on the sector will share insights and best practices for their 2021 plans.
Cell and Gene Therapies: Monday, January 11, 2021, 12 PM – 1 PM EST
This session gathers a panel of industry stakeholders to discuss what could be achieved if data were more easily and appropriately shared amongst all who have a critical role in a patient care, and how we might create this trusted environment and associated infrastructure to maintain safety, security, and privacy to enable the speed of science to develop even faster.
Healthcare Private Equity Leaders Forum (four topics)
Macroeconomic Outlook: Why it Takes a Global Pandemic to Reduce US Healthcare Expenditures: Tuesday, January 12, 2021, 12:15 – 12:35 PM EST
The macroeconomic impact of COVID-19 and the subsequent recession drove our national healthcare expenditure growth negative for the first time in 60+ years. Hear our speakers discuss the macroeconomic outlook for healthcare and the potential rebound implications for 2021.
Election and Policy Implications: Healthcare Regulatory and Policy Outlook with the New Administration: Tuesday, January 12, 2021, 12:35 – 1:15 PM EST
By mid-January, the Georgia senate race should be completed, along with the Biden administration transition. This seasoned panel of Washington insiders will analyze the policy implications and legislative agenda and its impact on the healthcare industry.
The Intersection of Private Equity and Health Systems: Tuesday, January 12, 2021, 1:15 – 1:55 PM EST
Recent PE activity has involved collaborations and partnerships with health systems in numerous ways, and this trend is likely to continue. Private equity is increasingly investing in entire health systems, exiting investments by selling to health systems, purchasing a division of a health system as either a platform or portfolio company add-on and engaging in other innovative joint ventures. Listen to our panelists discuss the how and why of the evolution of these partnerships and what the future holds for these creative deal structures.
2020: Year of the SPAC: Tuesday, January 12, 2021, 1:55 – 2:15 PM EST
An interactive panel of senior private equity professionals and healthcare bankers will discuss the proliferation of SPAC transactions in 2020, including illustrating the conditions that enabled the rise of SPACs this year and the outlook going forward.
Hospital & Health Systems (two topics)
CEO Panel: Strategic Business Priorities: Wednesday, January 13, 2021, 12:30 – 1:20 PM EST
New this year, hear how Chief Executive Officers are focusing on strategic business priorities in 2021 and beyond.
Legal and Financial Trends: Wednesday, January 13, 2021, 1:20 – 2 PM EST
Leading professionals will forecast critical legal, regulatory and financial trends facing hospitals and health systems and offer insight on how to position your organization to innovate, collaborate and grow in this dynamic environment.
Media are invited to attend the event this event. Visit the conference webpage for more information, including the full agenda and registration.
McDermott Will & Emery is the nation’s leading health law firm. The Health Industry Advisory group is the only health practice to receive top national rankings from U.S. News – Best Lawyers “Best Law Firms,” Chambers USA, The Legal 500 US, and Law360. The practice was also recognized by Chambers as “Health Team of the Year” in 2010, 2013, 2017 and 2019. McDermott has held the top spot in PitchBook’s League Tables as the most active firm for healthcare private equity since 2017.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
Media Contact
McDermott Comment | Lord Sugar Joins Challenge to Caffè Nero Turnaround
PRESS RELEASE
McDermott Comment | Lord Sugar Joins Challenge to Caffè Nero Turnaround
January 4, 2021
Read time: 2 min
Aymen Mahmoud, partner at law firm McDermott Will & Emery, said:
“This case highlights the need for creativity among market participants to create novel restructuring options or increase the value of options under the new corporate governance and insolvency regime. We can expect challenges which will force both the courts and the legislators to carefully examine the recent legislation under significant public policy scrutiny.”
Media Contact
Five McDermott Lawyers Recognized as Client Service All-Stars
PRESS RELEASE
Five McDermott Lawyers Recognized as Client Service All-Stars
December 16, 2020
Read time: 3 min
International law firm McDermott Will & Emery is proud to announce that five lawyers were named to BTI Consulting Group’s list of 2020 Client Service All-Stars. These honorees were identified based on nominations from general counsel and other legal decision-makers for their unwavering commitment and standout client service.
“In a year unlike any other, we are particularly pleased to congratulate our partners for BTI’s client-focused recognition,” said Ira Coleman, McDermott Chairman. “They are outstanding Partners in every respect and leaders in all that they do, not only within McDermott but also in our profession. Above all, they exemplify what it means to put our clients’ needs first—and we couldn’t be more proud.”
McDermott lawyers recognized as BTI Client Service All-Stars include:
- George Benson (Tax Planning and Litigation)
- Diane Morgenthaler (Employee Benefits and Executive Compensation)
- Michael Poulos (Consumer Fraud, Securities, and Insurance Litigation)
- David Rosenbloom (Litigation)
- Thomas Sauermilch (Mergers and Acquisitions)
Lawyers are nominated by legal decision makers based on five characteristics: superior client focus, unmatched client experience, understanding client’s business like no other, unparalleled legal skills and innovative thought leadership. All-stars are defined as those “who deliver incomparable levels of client service excellence” and “have an unquenchable thirst to understand their clients better than all other attorneys.”
To learn more about the lawyers recognized today, please visit our website.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
Media Contact
McDermott Tax Partners Recognized as “Most Effective Lawyers”
AWARDS & RANKINGS / PRESS RELEASE
McDermott Tax Partners Recognized as “Most Effective Lawyers”
December 15, 2020
Read time: 4 min
International law firm McDermott Will & Emery is proud to announce that three Miami-based partners were recognized by The Daily Business Review in its 16th Annual “Most Effective Lawyers” list. These awards recognize South Florida lawyers who have achieved exceptional results for their clients in the past year. Steven Hadjilogiou was honored in the International Transactions category and Michael Silva and Greg Weigand were honored in the Tax category.
“Steve, Greg and Mike each bring their personal passions and commitment to every client they serve,” said Jane May, global head of the Firm’s Tax Practice. “These three always take the time to understand the complexities of their clients’ businesses to help them navigate the ever-changing tax landscape and provide practical solutions.”
Steve focuses his practice on tax optimization of business operations and investments with a specific emphasis in the areas of international tax and real estate. Steve provides advice on international inbound and outbound tax planning for multinational companies, family offices, private equity and ultra-high net worth individuals. He also advises funds, family offices and ultra-high net worth individuals in connection with complex real estate structuring and investment issues, including in the areas of opportunity zone funds, 1031 transactions and qualified small business stock.
Mike is the chair of McDermott’s Miami Tax and Private Client practices, and co-chair of the firm’s Latin America practice. He focuses his practice on international tax law, with an emphasis on US investment structures, cross-border transactions, tax treaty planning and US activities of foreign banks. He has significant experience forming investment funds and advising family offices. He also advises Brazilian and Asian investors on investments in US real estate projects, and assists multinational corporations on establishing a business presence in the US.
Greg focuses his practice on domestic and international tax matters for multinational companies, closely held businesses, investment funds and high-net-wealth individuals. He advises US and foreign-based publicly traded and privately held companies on domestic and international mergers and acquisitions, financing transactions, and global restructuring transactions. Greg regularly advises asset managers and fund sponsors with the structuring of investment funds across various strategies, in addition to advising funds on transactional matters.
McDermott’s Tax Practice is a combination of practitioners, strategists and creative thinkers who offer innovative, and often unexpected, solutions to mitigate risks and drive growth for some of the world’s largest companies. Armed with the required technical prowess, McDermott tax lawyers dig deeper to gain a full understanding of each client’s corporate structure within the competitive landscape. Year after year, Chambers USA, US News-Best Lawyers, International Tax Review and The Legal 500 recognize the firm’s tax practice and individual lawyers as leaders in the industry. Whether planning, conducting diligence, actively negotiating, or tackling regulatory hurdles, McDermott has the insights, skills and resources to handle the most complex tax matters – 365 days a year with a 360-degree view of the evolving tax landscape.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
Media Contact
McDermott Will & Emery Announces the Appointment of a New Partner and Three Counsel in Paris
PRESS RELEASE
McDermott Will & Emery Announces the Appointment of a New Partner and Three Counsel in Paris
December 10, 2020
Read time: 5 min
McDermott Will & Emery continues its development strategy, consolidating its leading market position by co-opting Anne-France Moreau as Partner (corporate and life sciences) and appointing Katya Ascher (corporate and life sciences), Charlotte Michellet (public and regulatory law) and Romain Desmonts (tax law) as Counsel.
These appointments will be effective as of January 1, 2021.
Anne-France Moreau specializes in business law in the field of the Life Sciences, Health and Cosmetics industries. She advises pharmaceutical laboratories, biotech companies, specialized investment funds and other healthcare players, both French and foreign, in the context of their M&A transactions, partnerships, investments and in the negotiation of their strategic agreements. Notably, in 2020, Anne-France was a guide to L’Oréal in a licensing agreement with the Dutch biotech company Micreos, to Vétoquinol in the acquisition of the European and UK rights to Elanco Animal Health’s Profender® and Drontal® product families, to Egle in negotiations with Takeda, to Themis in its sale to Merck and to Diabeloop in its development agreement with Terumo.
Admitted to the Paris Bar, Anne-France holds a Master 2 in Business Law and European Law (University of Paris V – Descartes, 2008).
Katya Ascher specializes in patent and contract law with a focus on life sciences. She commenced her career in New York where she practiced for five years as a litigation and patent attorney, then working in the legal department of the Institut Pasteur in Paris. She then joined a law firm in London where she assisted numerous pharmaceutical and biotech companies in license and collaboration agreement negotiations. Katya joined the Life Sciences department of McDermott’s Paris office in 2018, where she will use her past experience in both negotiating R&D agreements and in strategic consulting for US, Swiss and French clients.
Admitted to the Paris, New York, England and Wales bars, Katya holds a Master 2 in Industrial Property (University of Paris II – Panthéon-Assas, 2012), a Juris Doctor, with honors (University of North Carolina School of Law – 2005) and a BA, Biology, with distinction (University of North Carolina at Chapel Hill – 2002).
Charlotte Michellet focuses her practice in the areas of public law, administrative law and regulated sectors such as transportation, energy and health, in both advisory and litigation practice areas. In particular, Charlotte assists clients before the administrative courts and also represents clients before independent administrative or supervisory authorities. Prior to joining McDermott, Charlotte worked for approximately three years as a legal officer in the legal department of the Conseil Supérieur de l’Audiovisuel, gaining extensive experience in the regulation of the audiovisual sector. Prior to that, she served as a legal assistant at the 5th Subsection of the Conseil d’État for two years.
Admitted to the Paris Bar, Charlotte holds a Master’s degree in Public Affairs from Sciences Po Paris (2009) and a Master 2 in Public Business Law (University of Paris I – Panthéon-Sorbonne, 2010).
Romain Desmonts mainly advises French and multinational groups on the domestic and international aspects of their mergers and acquisitions and internal reorganizations, as well as on their indirect tax issues. He also advises private clients on complex international asset structuring and trust issues, particularly in a Franco-American context. He frequently assists companies and private clients in the context of tax audits and tax litigation.
Admitted to the Paris Bar, Romain holds a Master 2 in Corporate Taxation (Université Paris-Dauphine, 2010) and an MBA-level degree in Management Sciences (Université Paris-Dauphine, 2009).
“The partners congratulate them each on their respective promotions. These four appointments are consistent with the continued development of our healthcare practices – life sciences, regulatory, tax law – and confirm our confidence in the future of McDermott, whose Paris office will celebrate its tenth anniversary in 2021,” said Grégoire Andrieux, Managing Partner.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
Media Contact
International Tax Powerhouse Bolsters McDermott’s West Coast Presence
PRESS RELEASE
International Tax Powerhouse Bolsters McDermott’s West Coast Presence
December 3, 2020
Read time: 4 min
International law firm McDermott Will & Emery is pleased to announce that Dominika Korytek has joined the Firm’s US and International Tax practice as a partner based in the San Francisco office. Dominika has extensive experience in international tax planning with a focus on technology companies, allowing her to integrate seamlessly into McDermott’s international tax group and further expand the West Coast practice.
“Our clients demand sophisticated and experienced advisors as they navigate the ever-increasingly complex international tax landscape. This is certainly true of technology and other multinational companies,” said Jane May, global head of McDermott’s Tax Practice “Dominika is a top-notch client advocate who further strengthens our cross-border practice. She has incredible experience in the field and we are thrilled to have her join our team.”
Dominika focuses her practice on international tax planning, with an emphasis on technology companies. She advises clients on tax strategies for international expansion, domestic and international acquisitions, reorganizations and dispositions.
“I am honored to join McDermott and practice among some of the best and brightest lawyers in the international tax field,” added Dominika. “Joining this team opens doors to so many opportunities, not only for me, but also for companies who need novel and creative solutions to navigate the complex and ever changing international tax landscape as they expand into new markets and launch new products. I know the McDermott platform will help propel their success.”
Prior to joining McDermott, Dominika was a member of Baker McKenzie’s North America Tax Practice Group’s Tax Planning and Transactions Committee and was Chair of the Diversity and Inclusion Committee for California. She is also included in the International Tax Review’s “Women in Tax Leaders” guide – a list of the world’s leading female tax practitioners.
Dominika received her BA from Cornell University, her JD from Thomas Jefferson School of Law and her LLM in Taxation from Georgetown University Law Center.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
Media Contact
McDermott Advises Kaiser Aluminum Corporation on Alcoa Warrick Acquisition
DEAL ANNOUNCEMENT / PRESS RELEASE
McDermott Advises Kaiser Aluminum Corporation on Alcoa Warrick Acquisition
November 30, 2020
Read time: 3 min
International law firm McDermott Will & Emery represented Kaiser Aluminum Corporation (NASDAQ:KALU) in its definitive agreement to purchase Alcoa Warrick LLC, containing all the assets of the Warrick Rolling Mill (Warrick), from Alcoa Corporation for a purchase price of $670 million. Warrick has a leading position in the North American aluminum packaging industry and the facility includes casting, significant hot and cold rolling capacity and a range of finishing and coating lines.
The transaction provides Kaiser Aluminum entry into the North American aluminum packaging industry. Alcoa will retain ownership of the related smelting assets, power plant and land. As part of the transaction, Kaiser Aluminum will enter into a market based molten aluminum supply agreement, and a long-term ground lease that includes provisions for utility services and will have customary transition services.
- The deal is valued at $670 million.
- This transaction is anticipated to close on or about March 31, 2021, subject to satisfaction of customary closing conditions and regulatory approvals.
- McDermott Will & Emery acted as legal counsel to Kaiser Aluminum Corporation.
- The McDermott team included Thomas Sauermilch, Meir Lewittes, Raymond Jacobsen, Joel Grosberg, Diane Morgenthaler, Kristin Michaels, Daphne Trotter, Jacob Hollinger, Elias Eliopoulos, Jason Krieser, Jed Gordon, Andrew Kratenstein, Thomas Conaghan and Daniel Zucker.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
Media Contact
McDermott Advises Silverfleet Capital on the Sale of Medical Workwear Innovators 7days to Chequers Capital and Paragon Partners
DEAL ANNOUNCEMENT / PRESS RELEASE
McDermott Advises Silverfleet Capital on the Sale of Medical Workwear Innovators 7days to Chequers Capital and Paragon Partners
November 30, 2020
Read time: 3 min
Munich, November 30, 2020 – McDermott Will & Emery advises the pan-European private equity firm Silverfleet Capital on the sale of its portfolio company 7days to a consortium of investors comprising Chequers Capital and Paragon Partners. Subject to regulatory approvals the transaction is expected to close in January 2021.
7days, founded in 1999, is a leading supplier of modern and innovative medical workwear. The company designs, manufactures and distributes a wide range of high-quality products for more than 300,000 customers in the healthcare sector in 12 countries, including Germany, Austria, Switzerland, France, Belgium, the Netherlands and Scandinavia.
Silverfleet invested in 7days from its mid-market fund in 2018, and has since then developed and implemented a successful transformation and internationalization strategy for the company. This included also the acquisition of Praxis Herning A/S, a Danish supplier of medical workwear in Scandinavia.
Silverfleet Capital has been active as a private equity investor in the European mid-market for more than 30 years. A team of 31 investment professionals working from Munich, Amsterdam, London, Paris and Stockholm focuses on industries such as financial services, healthcare, manufacturing, retail and consumer goods.
The McDermott team was led by Tobias Koppmann and included Carsten Böhm, Steffen Woitz, Daniel von Brevern, Philipp Schaeuble, Marcus Fischer, Claus Färber as well as Matthias Weingut, Benedikt Glossner, Frank Weiss and Franziska Leubner.
Lead partner Tobias Koppmann previously advised Silverfleet Capital on the acquisition of the 7days Group, and McDermott also advised Silverfleet Capital on the acquisition of Praxis Herning A/S at the end of 2018.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
Media Contact
McDermott Represents Center for Diagnostic Imaging in Acquisition of Smart Choice MRI
DEAL ANNOUNCEMENT / PRESS RELEASE
McDermott Represents Center for Diagnostic Imaging in Acquisition of Smart Choice MRI
November 25, 2020
Read time: 3 min
International law firm McDermott Will & Emery represented Center for Diagnostic Imaging (CDI), a portfolio company of private equity firm Wellspring Capital Management LLC, in its acquisition of Smart Choice MRI, an independent MRI provider with locations across the US Midwest.
- This transaction was completed on November 23, 2020.
- McDermott Will & Emery acted as legal counsel to Wellspring Capital Management LLC and its portfolio company Center for Diagnostic Imaging.
- McDermott’s representation also included an amendment to CDI’s senior secured credit facility with Cerberus Business Finance Agency, LLC, as the administrative agent and collateral agent for the lenders.
- McDermott has previously represented Wellspring in connection with its recent acquisitions of U.S. MRI, Cadence Petroleum Group, Paragon Films, Lucky Strike Entertainment and CDI Diagnostic Imaging. McDermott also represented Wellspring Capital Management in the sale of its portfolio company Help at Home.
- The McDermott team was led by Wellspring relationship partner Frank Steinherr and Scott Regan with healthcare regulatory support led by Sarah Kitchell; and additional support from Daniel Zucker, Jennifer Mikulina, Tony Maida, Ryan Higgins, Dan Martin, Joe Urwitz, Daphne Trotter, George Tzanetakos, Mark Collins, James Kim, Ana Koff, Emily Jewell, Dan Doron, Cody Ruegger and Bethany Hatef. The finance team was led by Stephanie McCann and Nicole Briody.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
Media Contact
McDermott Represents Center for Diagnostic Imaging in Acquisition of U.S. MRI
DEAL ANNOUNCEMENT / PRESS RELEASE
McDermott Represents Center for Diagnostic Imaging in Acquisition of U.S. MRI
November 24, 2020
Read time: 3 min
International law firm McDermott Will & Emery represented Center for Diagnostic Imaging, a portfolio company of private equity firm Wellspring Capital Management LLC, in its acquisition of U.S. MRI, the largest independent advanced medical imaging center in Utah.
- This transaction was completed on November 3, 2020.
- McDermott Will & Emery acted as legal counsel to Wellspring Capital Management LLC and its portfolio company Center for Diagnostic Imaging.
- McDermott represented Wellspring in connection with its recent acquisitions of Cadence Petroleum Group, Paragon Films, Lucky Strike Entertainment and CDI Diagnostic Imaging. Most recently, McDermott represented Wellspring Capital Management in the sale of its portfolio company Help at Home.
- McDermott’s representation also included an amendment to CDI’s senior secured credit facility with Cerberus Business Finance Agency, LLC, as the administrative agent and collateral agent for the lenders.
- The McDermott team was led by Wellspring relationship partner Frank Steinherr and Patrick Rowe, Smith Alpert and Emily Jewell with support from Sarah Kitchell, George Tzanetakos, Daniel Zucker, Ashley Fischer, Jennifer Mikulina, Harold Davidson, Dan Martin, Michelle Strowhiro, Joe Urwitz, Mark Collins and Bethany Hatef. Financial support was led by Stephanie McCann and Nicole Briody.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
